The Australian Cystic Fibrosis Data Registry Annual Report, 2017

Rasa Ruseckaite, Susannah Ahern, Thomas Alan Ranger, Joanne Dean, Madeleine Gardam, Scott C. Bell, Nettie Burke, on behalf of the Australian Cystic Fibrosis Data Registry

Research output: Book/ReportOther ReportOther


The ACFDR is a long standing registry which commenced in 1996. Since 1998 it has collected diagnostic and treatment data on over 90 percent of the population of cystic fibrosis (CF) patients in Australia, leading to a greater understanding of the disease’s characteristics and the standard and type of care provided to patients across Australia. Patients diagnosed with CF are invited to participate in the registry through their treating site. Data about a CF patient’s diagnosis, treatment and related complications are collected regularly with the aim to improve health service delivery and better understand the treatment of CF and outcomes for patients. The ACFDR dataset enables reporting in a manner generally consistent with other CF registries, such as in Europe, the United Kingdom and the United States.
Funded by Cystic Fibrosis Australia (CFA), the ACFDR is managed by Monash University, under a shared data custodianship arrangement. The registry is actively supported by a multidisciplinary Steering Committee, and project-related subcommittees. The composition of the current ACFDR Steering Committee is listed on page 43. The role of the Steering Committee is to lead the strategic direction of the ACFDR, to review requests for access to ACFDR data, to develop and review relevant ACFDR policies and procedures, and to review the quality of outputs from the Registry.
The ACFDR conforms to the national operating principles for clinical quality registries, as set out by the Australian Commission of Safety and Quality in Healthcare (ACSQHC). It has current ethical approval from Alfred Health for Monash University to manage and operate the registry. Patient recruitment is by the specialist CF centres and data collection is generally submitted by most sites by direct data entry using the ACFDR web–based interface, although increasingly
electronic transmission of data from electronic medical records or other databases to and from the registry is being requested. The ACFDR provides a publicly–available Annual Report and Jurisdictional Reports. It also provides annual reports to centres regarding centre data trends and comparisons. The ACFDR data may also be accessed by or analysed and provided to researchers and other interested parties, further information on which is available on page 39.
Original languageEnglish
Place of PublicationMelbourne, Australia
PublisherMonash University
Number of pages44
VolumeReport No 20
Publication statusPublished - Mar 2019


  • Cystic Fibrosis Australia
  • clinical quality registry

Cite this